Stock Rich List
#12560 on the rich list of 14,644 insiders

Mark Elliott Boulding

EXEC. VP AND CLO at PTC Therapeutics. Based in Warren, New Jersey.

$6.1M
in disclosed stock, −$201K (−3.16%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
12560th of 14,644
Companies held
1
Largest holding
PTCT, 100.0% of total
Latest SEC filing
Nov 16, 2026

What the $6.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
PTC Therapeutics PTCT
Common Stock
Directly105,272$58.33$6.1M100.0%Form 4, Nov 16, 2026

Share counts are the amounts Mark Elliott Boulding reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 16, 2026SoldPTCT1,315$61.39$81KView
Nov 16, 2026SoldPTCT1,288$62.22$80KView
Nov 16, 2026SoldPTCT209$62.90$13KView
Oct 9, 2026SoldPTCT192$64.26$12KView
Oct 6, 2026SoldPTCT435$64.16$28KView
Oct 5, 2026SoldPTCT1,638$64.03$105KView
Aug 17, 2026SoldPTCT969$72.90$71KView
Aug 17, 2026SoldPTCT1,844$72.39$133KView
Jul 6, 2026SoldPTCT833$84.41$70KView
Jul 6, 2026SoldPTCT313$83.10$26KView
Jul 6, 2026SoldPTCT745$86.38$64KView
Jul 6, 2026SoldPTCT519$85.84$45KView
Jul 6, 2026SoldPTCT1,036$84.41$87KView
Jul 6, 2026SoldPTCT387$83.10$32KView
Jul 6, 2026SoldPTCT601$86.38$52KView
Jul 6, 2026SoldPTCT645$85.84$55KView
Jun 17, 2026SoldPTCT1,850$79.24$147KView
Jun 17, 2026SoldPTCT1,703$78.50$134KView
Jun 17, 2026SoldPTCT309$79.25$24KView
Jun 17, 2026SoldPTCT6,600$78.50$518KView
May 15, 2026SoldPTCT456$72.67$33KView
May 15, 2026SoldPTCT2,356$72.08$170KView
May 8, 2026SoldPTCT840$78.23$66KView
May 8, 2026SoldPTCT1,900$79.31$151KView
May 8, 2026SoldPTCT200$78.00$16KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
12557James Cullen
Director, Keysight Technologies. Santa Rosa, CA
$6.1M−$106K (−1.70%)
12558Bradford T. Nordholm
Chief Executive Officer, Federal Agricultural Mortgage. Washington, DC
$6.1M−$109K (−1.75%)
12559R. Steven Hamner
Executive Vice President & CFO, Medical Properties Trust. Birmingham, AL
$6.1M+$37K (+0.61%)
12560Mark Elliott Boulding
EXEC. VP AND CLO, PTC Therapeutics. Warren, NJ
$6.1M−$201K (−3.16%)
12561Joseph J. Beacom
President of LSHI, Landstar System. Jacksonville, FL
$6.1M−$42K (−0.68%)
12562Emily Luisa Hill
Chief Financial Officer, Replimune Group. Woburn, MA
$6.1M−$191K (−3.01%)
12563Sunil Cutinho
Chief Information Officer, CME Group. Chicago, IL
$6.1M−$79K (−1.27%)

Other PTC Therapeutics insiders

All PTCT insiders

Questions

How much stock does Mark Elliott Boulding own?

Mark Elliott Boulding holds $6,139,989 in listed stock based on SEC filings and current prices, mostly PTC Therapeutics (PTCT). That ranks 12560th on the Stock Rich List.

Is this Mark Elliott Boulding's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mark Elliott Boulding last buy or sell stock?

The most recent open-market trade on file is a sale of 1,315 PTCT shares on Nov 16, 2026 at $61.39.